TITLE

Alvimopan for the Management of Postoperative Ileus After Bowel Resection: Characterization of Clinical Benefit by Pooled Responder Analysis

AUTHOR(S)
Ludwig, Kirk; Viscusi, Eugene R.; Wolff, Bruce; Delaney, Conor G.; Senagore, Anthony P.; Techner, Lee
PUB. DATE
September 2010
SOURCE
World Journal of Surgery;Sep2010, Vol. 34 Issue 9, p2185
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A pooled post hoc responder analysis was performed to assess the clinical benefit of alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist, for the management of postoperative ileus after bowel resection. Adult patients who underwent laparotomy for bowel resection scheduled for opioid-based intravenous patient-controlled analgesia received oral alvimopan or placebo preoperatively and twice daily postoperatively until hospital discharge or for 7 postoperative days. The proportion of responders and numbers needed to treat (NNT) were examined on postoperative days (POD) 3–8 for GI-2 recovery (first bowel movement, toleration of solid food) and hospital discharge order (DCO) written. Alvimopan significantly increased the proportion of patients with GI-2 recovery and DCO written by each POD ( P < 0.001 for all). More patients who received alvimopan achieved GI-2 recovery on or before POD 5 (alvimopan, 80%; placebo, 66%) and DCO written before POD 7 (alvimopan, 87%; placebo, 72%), with corresponding NNTs equal to 7. On each POD analyzed, alvimopan significantly increased the proportion of patients who achieved GI-2 recovery and DCO written versus placebo and was associated with relatively low NNTs. The results of these analyses provide additional characterization and support for the overall clinical benefit of alvimopan in patients undergoing bowel resection.
ACCESSION #
52760334

 

Related Articles

  • Safety and efficacy update: alvimopan in postoperative ileus. Beattie, David T. // Clinical Medicine: Therapeutics;2009, Issue 1, p199 

    Postoperative ileus (POI) in patients undergoing abdominal surgery is associated with signifi cant morbidity. In 2008, alvimopan (Entereg®) was approved by the Food and Drug Administration (FDA), and is the only available POI therapy in the United States for patients undergoing bowel...

  • Small Bowel Obstruction Due to Broad Ligament Hernia Successfully Treated by Laparoscopy. Garcia-Oria, Miguel; Inglada, Josep; Domingo, Josep; Biescas, Jordi; Ching, Christine // Journal of Laparoendoscopic & Advanced Surgical Techniques;Oct2007, Vol. 17 Issue 5, p666 

    We present the second case of a broad ligament hernia to be treated by laparoscopy. A 43-year-old gravida 0, para 0 woman presented to our hospital with a chief complaint of right upper quadrant abdominal colicky pain and vomiting. Her clinical history was significant for an...

  • Biological mesh repair of a strangulated perineal hernia following abdominoperineal resection. Fallis, Simon A.; Taylor, Lewis H.; Tiramularaju, R. M. R. // Journal of Surgical Case Reports;Apr2013, Vol. 2013 Issue 4, Special section p1 

    Perineal hernia is a recognized but uncommon complication following proctectomy. Emergency presentations of this hernia are very rare and are not well described in the literature. We present the case of an 81-year-old lady who presented with small bowel obstruction with strangulation secondary...

  • Primary resection and anastomosis for complicated meconium ileus: a safe procedure? Jawaheer, Jhalini; Khalil, Basem; Plummer, Tyasha; Bianchi, Adrian; Morecroft, James; Rakoczy, George; Bruce, James; Bowen, John; Morabito, Antonino // Pediatric Surgery International;Nov2007, Vol. 23 Issue 11, p1091 

    Various options are available for the surgical treatment of meconium ileus (MI). This paper examines the use of resection and primary anastomosis as the favoured option for the treatment of complicated meconium ileus. This was a retrospective study. All patients (13 children) with MI treated...

  • Alvimopan for postoperative ileus: Only one piece of the puzzle. Kraft, Michael D. // American Journal of Health-System Pharmacy;7/15/2009, Vol. 66 Issue 14, p1309 

    In this article the author discusses the therapeutic use of Alvimopan, an opioid antagonist drug, for patients with open abdominal surgery with bowel resection and for postoperative ileus in the U.S. The use of Alvimopan for patients with bowel resection has been proven to be efficient for...

  • Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery. Viscusi, E.; Goldstein, S.; Witkowski, T.; Andonakakis, A.; Jan, R.; Gabriel, K.; Du, W.; Techner, L.; Wallin, B. // Surgical Endoscopy;Jan2006, Vol. 20 Issue 1, p64 

    Background: Alvimopan is a peripherally acting muopioid receptor (PAM-OR) antagonist for accelerating gastrointestinal recovery after surgery. Methods: Patients undergoing open laparotomy (bowel resection, n = 418; hysterectomy, n = 197) were randomized to receive alvimopan 6 or 12 mg or placebo...

  • Laparoscopic Surgery for the Management of Obstruction of the Gastric Outlet and Small Bowel Following Previous Laparotomy for Major Upper Gastrointestinal Resection or Cancer Palliation: A New Concept. Al-Rashedy, Mohammed; Issa, M. Eyad; Ballester, Pedro; Ammori, Basil J. // Journal of Laparoendoscopic & Advanced Surgical Techniques;Apr2005, Vol. 15 Issue 2, p153 

    Background: Surgical relief of gastric outlet obstruction (GOO) or small bowel obstruction in patients who had undergone major resection or palliative bypass surgery for malignancy is conventionally achieved at a laparotomy. The potential role of minimally invasive surgery in the management of...

  • Long-term efficacy of strictureplasty for Crohn's disease. Uchino, Motoi; Ikeuchi, Hiroki; Matsuoka, Hiroki; Matsumoto, Takayuki; Takesue, Yoshio; Tomita, Naohiro // Surgery Today;Oct2010, Vol. 40 Issue 10, p949 

    Purpose: Strictureplasty (SP) is an established surgical option for the management of obstructive Crohn's disease (CD) to avoid an extended resection. This study reviewed this department's extensive experience with SP as treatment for obstructive CD to clarify its long-term efficacy and...

  • Abdominal actinomycosis presenting as a small-bowel obstruction. Horvat, Matjai; Kovačič, Srečko; Potrč, Stojan; Reberšelk-Gorišek, Helena // Wiener Klinische Wochenschrift;2004 Supplement 2, Vol. 116, p97 

    A 48-year-old female, presented as a case of acute abdomen with a small-bowel obstruction and a palpable hypogastric mass, was urgently operated. Laparotomy revealed a tumor mass of unknown origin that included a loop of the small bowel by compressing it. Resection of the tumor including a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics